A detailed history of Park Edge Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Park Edge Advisors, LLC holds 26,237 shares of PFE stock, worth $735,947. This represents 0.22% of its overall portfolio holdings.

Number of Shares
26,237
Previous 28,217 7.02%
Holding current value
$735,947
Previous $812,000 10.34%
% of portfolio
0.22%
Previous 0.3%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

SELL
$25.89 - $29.73 $51,262 - $58,865
-1,980 Reduced 7.02%
26,237 $728,000
Q4 2023

Jan 12, 2024

SELL
$26.13 - $33.94 $6,245 - $8,111
-239 Reduced 0.84%
28,217 $812,000
Q3 2023

Oct 11, 2023

BUY
$32.09 - $37.51 $7,669 - $8,964
239 Added 0.85%
28,456 $944 Million
Q2 2023

Jul 13, 2023

SELL
$36.12 - $41.79 $29,762 - $34,434
-824 Reduced 2.84%
28,217 $1.04 Billion
Q1 2023

Apr 18, 2023

BUY
$39.39 - $51.28 $31,512 - $41,024
800 Added 2.83%
29,041 $1.18 Billion
Q4 2022

Apr 14, 2023

BUY
$41.75 - $54.5 $1.18 Million - $1.54 Million
28,241 New
28,241 $1.45 Billion

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Park Edge Advisors, LLC Portfolio

Follow Park Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Park Edge Advisors, LLC with notifications on news.